Monday, March 22, 2010

Baxa announces new features to DoseEdge

Baxa Corporation Announces The Release Of New Features in its DoseEdge™ Workflow Management System

The product’s newly released upgrades offer expansive dose management options for health-system pharmacies.

Englewood, Colo. – March 22, 2010 – Baxa Corporation, a leading provider of medical devices and systems that automate pharmacy operations and increase patient safety, today announced the release of new features for its DoseEdge Pharmacy Workflow Management System.  The upgrades extend DoseEdge capabilities to include mobile dose tracking, more pharmacist verification options and enhanced dose status monitoring. 
Along with a range of configurable options that add new security parameters to the verification process, DoseEdge users also gain access to extended scanning capabilities.  This enables new tracking options for scan-tracking doses outside the pharmacy.  An easy-to-read, programmable Status Board displays key dose information to appropriate health-system staff, enabling pharmacists and technicians to spend more time focusing on patient safety and less time chasing lost doses.

“Now, health-system pharmacists can use a better, more robust, integrated system to safely and efficiently prepare a broader range of doses, including oral doses,” said Dennis Tribble, PharmD, Baxa Chief Pharmacy Officer.  “Our team of pharmacy experts focused on key features that will give DoseEdge users further confidence during the IV and oral medication preparation processes, as well as flexible tools that will improve both verification and tracking.”

Product Availability
DoseEdge Pharmacy Workflow Manager is available immediately.  For more information about Baxa DoseEdge products, please visit

About Baxa Corporation
Baxa Corporation is a Denver-based manufacturer of medical devices and systems for preparing, handling, packaging, and administering liquid medications. The company manufactures and markets a wide range of healthcare products for use in hospitals, critical care units and alternate-site pharmacies. Privately held, Baxa Corporation has subsidiaries in Canada and the United Kingdom, sales infrastructure in Austria, Belgium, Finland, France, Germany, Luxembourg, The Netherlands and Switzerland; and distribution partners worldwide. Further information is available at

No comments:

Post a Comment